Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 611
Gene Symbol: OPN1SW
OPN1SW
0.060 Biomarker disease BEFREE Based on these results, CBT-E seems suitable for adolescent patients with anorexia nervosa seeking treatment in a real-world clinical setting. 31199022 2019
Entrez Id: 611
Gene Symbol: OPN1SW
OPN1SW
0.060 Biomarker disease BEFREE Therefore, classifying individuals as "severe and enduring" appears to lack clinical utility in CBT-E. Clinicians should continue to administer evidence-supported treatments such as CBT-E for patients with AN, regardless of duration or severity of AN illness.(PsycINFO Database Record 30035586 2018
Entrez Id: 611
Gene Symbol: OPN1SW
OPN1SW
0.060 Biomarker disease BEFREE Hence, we compared short- and long-term outcomes of inpatient enhanced cognitive-behavioural therapy (CBT-E) in patients with anorexia nervosa who had and had not suffered sexual abuse. 28927864 2018
Entrez Id: 611
Gene Symbol: OPN1SW
OPN1SW
0.060 GeneticVariation disease BEFREE Our data suggest that the DSM-5 severity specifiers for anorexia nervosa may have limited clinical utility in predicting treatment outcomes of CBT-E. 30059831 2018
Entrez Id: 611
Gene Symbol: OPN1SW
OPN1SW
0.060 Biomarker disease BEFREE Within the Anorexia Nervosa Treatment of Out Patients (ANTOP) study, the largest multisite outpatient intervention trial in anorexia nervosa (AN) to date, manualised enhanced cognitive-behavioural therapy (CBT-E) was offered as one treatment modality. 30380658 2018
Entrez Id: 611
Gene Symbol: OPN1SW
OPN1SW
0.060 Biomarker disease BEFREE These findings suggest that inpatient CBT-E is well accepted by patients with AN, and could also be a viable and promising treatment for those with SE-AN. 27863331 2017